Literature DB >> 15212126

Complete off-pump coronary revascularization in patients with dialysis-dependent renal disease.

Vedat Erentug1, Esat Akinci, Kaan Kirali, Nihan Kayalar, Evren Kaynak, Halide Ogus, Denyan Mansuroglu, Nilgun Ulusoy Bozbuga, Cevat Yakut.   

Abstract

Patients who have dialysis-dependent renal disease frequently present with coronary artery disease but are considered at high risk for coronary artery bypass grafting. From 1 September 2000 through 31 August 2003, we performed complete off-pump coronary revascularization in 6 patients who had end-stage dialysis-dependent renal failure, and we prospectively studied the perioperative and early postoperative results. The effect of off-pump coronary artery bypass grafting on mortality, morbidity, postoperative complications, and transfusion requirements in this group of patients was investigated. No perioperative deaths or ischemic cardiac events were observed after off-pump coronary artery bypass grafting. In all patients, anginal symptoms were relieved during the postoperative period. The mean duration of follow-up was 172 +/- 12.4 months. Patients with dialysis-dependent chronic renal failure who present with coronary artery disease should be thoroughly evaluated preoperatively for risk factors and coexistent severe diseases. We believe that in patients with end-stage dialysis-dependent chronic renal failure, off-pump coronary revascularization is a good alternative.

Entities:  

Mesh:

Year:  2004        PMID: 15212126      PMCID: PMC427375     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  9 in total

1.  Cardiac surgery in patients with dialysis-dependent renal disease.

Authors:  S Suehiro; T Shibata; Y Sasaki; T Murakami; M Hosono; H Fujii; H Kinoshita
Journal:  Ann Thorac Cardiovasc Surg       Date:  1999-12       Impact factor: 1.520

2.  Cardiac surgery in patients with end-stage renal disease: 10-year experience.

Authors:  M Horst; U Mehlhorn; S P Hoerstrup; M Suedkamp; E R de Vivie
Journal:  Ann Thorac Surg       Date:  2000-01       Impact factor: 4.330

3.  Comparison of clinical outcomes of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty in renal dialysis patients.

Authors:  T Koyanagi; H Nishida; M Kitamura; M Endo; H Koyanagi; M Kawaguchi; N Magosaki; T Sumiyoshi; S Hosoda
Journal:  Ann Thorac Surg       Date:  1996-06       Impact factor: 4.330

4.  Causes of death. United States Renal Data System.

Authors: 
Journal:  Am J Kidney Dis       Date:  1998-08       Impact factor: 8.860

5.  Coronary artery bypass grafting in patients on chronic hemodialysis: surgical outcome in diabetic nephropathy versus nondiabetic nephropathy patients.

Authors:  Y Hosoda; T Yamamoto; K Takazawa; M Yamasaki; S Yamamoto; I Hayashi; K Kudoh
Journal:  Ann Thorac Surg       Date:  2001-02       Impact factor: 4.330

6.  Uremic lipemia. An unrecognized abnormality in triglyceride production and removal.

Authors:  J D Bagdade
Journal:  Arch Intern Med       Date:  1970-11

7.  Early and long-term results of coronary artery bypass grafting in dialysis patients.

Authors:  D L Franga; J M Kratz; A J Crumbley; J L Zellner; M R Stroud; F A Crawford
Journal:  Ann Thorac Surg       Date:  2000-09       Impact factor: 4.330

8.  Coronary artery bypass grafting in dialysis patients.

Authors:  W G Marshall; N P Rossi; R L Meng; T Wedige-Stecher
Journal:  Ann Thorac Surg       Date:  1986-12       Impact factor: 4.330

9.  Survival rates of 2,728 patients with end-stage renal disease.

Authors:  W L Hellerstedt; W J Johnson; N Ascher; C M Kjellstrand; R Knutson; F L Shapiro; S Sterioff
Journal:  Mayo Clin Proc       Date:  1984-11       Impact factor: 7.616

  9 in total
  2 in total

1.  Coronary surgery in dialysis-dependent patients with end stage renal failure.

Authors:  S M Tugtekin; K Alexiou; Ch Georgi; U Kappert; M Knaut; K Matschke
Journal:  Z Kardiol       Date:  2005-10

2.  Effects of cardiopulmonary bypass on dialysis-dependent patients.

Authors:  Nursen Tanrikulu; Baburhan Ozbek
Journal:  Cardiovasc J Afr       Date:  2019-05-24       Impact factor: 1.167

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.